NCT00284739View on ClinicalTrials.gov

Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Abdominal AbscessPelvic Abscess
Interventions
DRUG

Alteplase

2mg or 4mg given twice daily for three days into loculated abscess

OTHER

saline

saline injection twice daily for three days

Trial Locations (1)

96819

Kaiser Foundation Hospital, Honolulu

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Kaiser Permanente

OTHER